Form 3 - Initial statement of beneficial ownership of securities

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 3 - Initial statement of beneficial ownership of securities

Tyra Biosciences (NASDAQ:TYRA)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Tyra Biosciences Charts.

Tyra Biosciences (NASDAQ:TYRA)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Tyra Biosciences Charts.

Tyra Biosciences Inc News

Tyra Biosciences to Present at Upcoming Investor Conferences
Tuesday 11 February 2025 (6 days ago) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Wednesday 5 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 29 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors
Wednesday 29 January 2025 (3 weeks ago) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Wednesday 22 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Tyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers Symposium
Wednesday 22 January 2025 (4 weeks ago) • PR Newswire (US)

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)
Friday 10 January 2025 (1 month ago) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Monday 9 December 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 6 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 5 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 2 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 20 November 2024 (3 months ago) • Edgar (US Regulatory)

More Tyra Biosciences Inc News Articles

Werner Enterprises

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions